Table 1.

Patient characteristics

Patent no.	Age	Gender	Duration	Location	Cervical level	Pre VAS	Post VAS	1 month follow-up VAS	3 months follow-up VAS	Pre VonFrey	Post von Frey	Number of treatments	DM history	HTN history
1	58	F	2	R	C5	10.00	4.00	4.00	5.00	0.008	0.008	5	N	N
2	64	M	2	L	C5	7.00	3.00	4.00	2.00	0.008	0.008	10	Y	Y
3	73	M	1	L	C2–C4	7.00	3.00	3.00	4.00	0.008	0.008	4	N	Y
4	77	M	2	R	C3–C4	6.00	3.00	3.00	4.00	0.008	0.008	7	N	Y
5	65	F	1	L	C2–C3	6.00	3.00	1.00	0.00	0.004	0.008	13	N	N
6	64	F	1	L	C2–C5	6.00	2.00	2.00	0.00	0.04	0.008	3	N	N
7	60	F	2	R	C5	9.00	7.00	7.00	6.00	0.07	0.008	13	Y	Y
8	61	F	2	L	C4	9.00	5.00	5.00	5.00	0.02	0.008	17	Y	Y
9	67	M	1	R	C5–C8	7.00	3.00	3.00	2.00	1	0.008	5	N	Y
10	40	F	1	R	C2–C3	7.00	2.00	3.00	2.00	0.008	0.008	10	N	Y
11	72	M	1	L	C3–C4	9.00	3.00	3.00	1.00	0.008	0.008	20	N	N
12	59	F	1	R	C5–C6	10.00	3.00	4.00	2.00	0.008	0.008	14	N	N
13	64	F	1	L	C5	6.00	2.00	2.00	0.00	0.008	0.008	4	N	N
14	79	F	1	L	C5–C6	6.00	1.00	1.00	0.00	0.02	0.008	7	N	N
15	53	M	1	R	C4–C6	7.00	4.00	5.00	6.00	0.008	0.008	12	Y	N
16	58	F	1	L	C3	7.00	2.00	3.00	4.00	0.008	0.008	10	Y	Y
17	58	F	3	R	C5	7.00	4.00	5.00	7.00	0.008	0.008	10	Y	Y
18	80	F	3	L	C4–C5	7.00	5.00	5.00	6.00	0.008	0.008	15	Y	N
19	53	F	4	R	C6	6.00	5.00	6.00	5.00	6	1	5	Y	N
20	79	M	4	R	C2–C5	5.00	2.00	2.00	3.00	0.008	0.008	14	N	Y
21	59	F	36	R	C2–C4	9.00	6.00	5.00	5.00	8	0.4	8	Y	Y
22	59	F	7	L	C7–C8	7.00	5.00	5.00	5.00	0.008	0.008	10	Y	Y
23	77	M	48	R	C6	7.00	3.00	4.00	5.00	0.008	0.008	11	N	N
24	66	M	18	L	C7–C8	8.00	4.00	6.00	7.00	4	0.4	11	Y	Y
25	60	M	9	R	C7	5.00	4.00	3.00	3.00	0.4	0.4	4	N	Y
26	70	F	24	L	C5	6.00	3.00	4.00	2.00	1	1	10	N	Y
27	80	F	8	R	C3–C4	7.00	5.00	4.00	4.00	0.2	0.2	3	Y	N
28	43	F	12	R	C2–C3	5.00	1.00	2.00	2.00	0.008	0.008	5	N	N
29	70	M	14	L	C5	5.00	4.00	2.00	4.00	0.002	0.008	15	Y	N
30	57	F	36	R	C5	8.00	4.00	5.00	4.00	0.008	0.008	6	N	N

Abbreviations: VAS, visual analog scale; DM, diabetes mellitus; HTN, hypertension; M, male; F, female; L, left; R, right; Y, yes; N, no.